Vir Biotechnology president and CEO George Scangos paints a picture of the future of biotechnology, including a vision for building safe, ethical gene therapies for many common diseases. Furthermore, he adds, advances in genomics may also allow us to significantly improve the speed and safety of clinical trials for new drugs.
Related

Video
Innovation
Building Better Online Communities [Entire Talk]
Sarah Friar, Nextdoor
49 minutes

Video
Innovation
The Language of Technology [Entire Talk]
Ravi Mhatre, Lightspeed Venture Partners
45 minutes

Video
Innovation
Making a Difference in Biotech [Entire Talk]
George Scangos, Vir Biotechnology
44 minutes

Video
Innovation
Innovating for Equity [Entire Talk]
Adam Pisoni, Abl Schools
48 minutes